rs114750216

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_004369.4(COL6A3):​c.1182C>T​(p.Thr394=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00585 in 1,613,934 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0044 ( 5 hom., cov: 33)
Exomes 𝑓: 0.0060 ( 34 hom. )

Consequence

COL6A3
NM_004369.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.230
Variant links:
Genes affected
COL6A3 (HGNC:2213): (collagen type VI alpha 3 chain) This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 2-237387712-G-A is Benign according to our data. Variant chr2-237387712-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 94902.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-237387712-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.23 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0044 (670/152296) while in subpopulation NFE AF= 0.00598 (407/68032). AF 95% confidence interval is 0.0055. There are 5 homozygotes in gnomad4. There are 309 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
COL6A3NM_004369.4 linkuse as main transcriptc.1182C>T p.Thr394= synonymous_variant 4/44 ENST00000295550.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
COL6A3ENST00000295550.9 linkuse as main transcriptc.1182C>T p.Thr394= synonymous_variant 4/441 NM_004369.4 P1P12111-1

Frequencies

GnomAD3 genomes
AF:
0.00440
AC:
670
AN:
152178
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000989
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00458
Gnomad ASJ
AF:
0.0259
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.00518
Gnomad FIN
AF:
0.00169
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00598
Gnomad OTH
AF:
0.00527
GnomAD3 exomes
AF:
0.00588
AC:
1474
AN:
250708
Hom.:
8
AF XY:
0.00612
AC XY:
829
AN XY:
135534
show subpopulations
Gnomad AFR exome
AF:
0.000433
Gnomad AMR exome
AF:
0.00319
Gnomad ASJ exome
AF:
0.0231
Gnomad EAS exome
AF:
0.000436
Gnomad SAS exome
AF:
0.00815
Gnomad FIN exome
AF:
0.00273
Gnomad NFE exome
AF:
0.00652
Gnomad OTH exome
AF:
0.0113
GnomAD4 exome
AF:
0.00600
AC:
8772
AN:
1461638
Hom.:
34
Cov.:
32
AF XY:
0.00607
AC XY:
4416
AN XY:
727088
show subpopulations
Gnomad4 AFR exome
AF:
0.000986
Gnomad4 AMR exome
AF:
0.00333
Gnomad4 ASJ exome
AF:
0.0241
Gnomad4 EAS exome
AF:
0.000227
Gnomad4 SAS exome
AF:
0.00831
Gnomad4 FIN exome
AF:
0.00279
Gnomad4 NFE exome
AF:
0.00591
Gnomad4 OTH exome
AF:
0.00682
GnomAD4 genome
AF:
0.00440
AC:
670
AN:
152296
Hom.:
5
Cov.:
33
AF XY:
0.00415
AC XY:
309
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.000987
Gnomad4 AMR
AF:
0.00458
Gnomad4 ASJ
AF:
0.0259
Gnomad4 EAS
AF:
0.000579
Gnomad4 SAS
AF:
0.00518
Gnomad4 FIN
AF:
0.00169
Gnomad4 NFE
AF:
0.00598
Gnomad4 OTH
AF:
0.00522
Alfa
AF:
0.00765
Hom.:
3
Bravo
AF:
0.00488
Asia WGS
AF:
0.00606
AC:
21
AN:
3478
EpiCase
AF:
0.00812
EpiControl
AF:
0.00706

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxDec 22, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 28, 2021- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 05, 2012- -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMar 01, 2024COL6A3: BP4, BS2 -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Ullrich congenital muscular dystrophy 1A;C4225336:Dystonia 27;CN029274:Bethlem myopathy 1A Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 20, 2021- -
Collagen 6-related myopathy Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Bethlem myopathy 1A Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 24, 2024- -
COL6A3-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesDec 22, 2020This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
11
DANN
Benign
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs114750216; hg19: chr2-238296355; COSMIC: COSV55099695; API